Ferlazzo, Guido
Università degli Studi di Genova,
Italy
2025 Rank: 102570
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2740 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102570 | 99357 |
| Total Cites | 7777 | 8963 |
| H-index | 44 | 47 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 39 | 54 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 2730 | 3153 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 4576 | 5265 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6096 | 6570 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.36 |
| Self-Citation Percentage |
13.23%
|
|
Ferlazzo, Guido
Università degli Studi di Genova,
Italy
2024 Rank: 100931
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2754 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100931 | 96934 |
| Total Cites | 7238 | 8380 |
| H-index | 42 | 46 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 37 | 52 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 2658 | 3078 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 4353 | 5027 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5606 | 6052 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.38 |
| Self-Citation Percentage |
13.63%
|
|
Ferlazzo, Guido
IRCCS San Martino Polyclinic Hospital,
Italy
2023 Rank: 96670
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2655 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 96670 | 93817 |
| Total Cites | 6720 | 7833 |
| H-index | 40 | 43 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 38 | 53 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 2590 | 3009 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 4140 | 4805 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5151 | 5573 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.41 |
| Self-Citation Percentage |
14.21%
|
|
Ferlazzo, Guido
Università degli Studi di Messina,
Italy
2022 Rank: 96592
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2715 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 96592 | 92350 |
| Total Cites | 6001 | 7047 |
| H-index | 38 | 41 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 36 | 51 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 2438 | 2848 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 3801 | 4446 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4556 | 4944 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.43 |
| Self-Citation Percentage |
14.84%
|
|
Ferlazzo, Guido
Università degli Studi di Messina,
Italy
2021 Rank: 93383
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2631 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 93383 | 89967 |
| Total Cites | 5714 | 6733 |
| H-index | 38 | 41 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 35 | 50 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 2387 | 2796 |
| Number of Single+First+Last Authored Papers | 61 | 61 |
| Total Cites to Single+First+Last Authored Papers | 3681 | 4323 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4313 | 4682 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.44 |
| Self-Citation Percentage |
15.13%
|
|
Ferlazzo, Guido
Università degli Studi di Messina,
Italy
2020 Rank: 94673
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2636 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94673 | 87799 |
| Total Cites | 5059 | 6002 |
| H-index | 35 | 39 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 33 | 48 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 2270 | 2673 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 3341 | 3958 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3799 | 4119 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.46 |
| Self-Citation Percentage |
15.71%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.